Arch Venture Corp »

Phoenix Biotech Acquisition Class A shares owned by Arch Venture Corp

Quarter-by-quarter ownership of Phoenix Biotech Acquisition Class A (CERO) shares owned by Arch Venture Corp from 13F filings

Historical chart of Arch Venture Corp investment in Phoenix Biotech Acquisition Class A

Tip: Access up to 7 years of quarterly data

All positions including Phoenix Biotech Acquisition Class A held by Arch Venture Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phoenix Biotech Acquisition Class A by Arch Venture Corp

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.4M 1.4M 3.07

More positions owned by Arch Venture Corp

Verve Therapeutics (VERV)
Erasca (ERAS)
Gossamer Bio (GOSS)
Denali Therapeutics (DNLI)
Q32 Bio
Cero Therapeutics Holdings Class A Com (CERO)
Singular Genomics Systems In (OMIC)
Unity Biotechnology (UBX)

View all positions for Arch Venture Corp

Top funds holding Phoenix Biotech Acquisition Class A

Arch Venture Corp
Sc China Holding
Jane Street
Geode Capital Management
FNY Investment Advisers
Kestra Private Wealth Services
Pineridge Advisors
Jpmorgan Chase & Co

View all funds holding Phoenix Biotech Acquisition Class A